₹ 4.1
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Kobo Biotech Ltd. operates within the pharmaceutical industry, primarily focusing on the production of active pharmaceutical ingredients (APIs) through fermentation technology. The company was established on August 3, 1992, and its headquarters are situated in Mumbai, India.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overvalued on P/FCF.
Data is available to registered users only